DENTSPLY SIRONA (XRAY) has moved back into focus after renewing its long running U.S. technology distribution deal with Patterson Dental, and expanding its partnership with Benco Dental to cover its full digital portfolio.

The renewed Patterson agreement and broader Benco rollout arrive after a mixed stretch for the stock, with a 6.82% 1 month share price return but a 31.77% 1 year total shareholder return decline. This suggests longer term confidence has been weaker even as shorter term momentum has picked up slightly around these distribution moves and governance changes.

If this kind of dental technology story interests you, it can be worth scanning a wider set of healthcare names using healthcare stocks to see how other businesses are positioning themselves.

With the share price down sharply over 1 and 3 years, but an intrinsic value estimate implying a sizeable discount and a modest gap to the average analyst target, is XRAY now mispriced value or is the market already baking in any recovery?

Most Popular Narrative: 5% Undervalued

The most followed valuation narrative pegs DENTSPLY SIRONA's fair value close to the current US$12.21 share price, with only a small discount implied.

Disciplined capital allocation toward innovation, organic growth, and financial flexibility, along with new leadership focused on execution, positions DENTSPLY SIRONA to capitalize on long-term industry consolidation and the shift toward value-based, high-quality dental care, which should support multi-year top-line and bottom-line growth.

Curious what kind of revenue trajectory, margin reset and future earnings multiple need to line up for that outcome to work? The full narrative spells it out.

Result: Fair Value of $12.83 (UNDERVALUED)

However, the story can break if revenue softness persists and cost pressures, including higher tariffs, keep margins under strain longer than analysts currently model.

Build Your Own DENTSPLY SIRONA Narrative

If you see the setup differently or just want to stress test the assumptions yourself, you can build your own data driven view in a few minutes with Do it your way.

A great starting point for your DENTSPLY SIRONA research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Before you move on, take a few minutes to line up your next watchlist candidates using a handful of focused screeners that keep the process simple and practical.

• Spot potential bargains early by scanning these 863 undervalued stocks based on cash flows that currently trade below what their cash flows might suggest.
• Tap into the growth story around automation and data by checking out these 24 AI penny stocks reshaping how software and hardware work together.
• Add income angles to your mix with these 12 dividend stocks with yields > 3% that offer yields above 3% and can complement more growth oriented ideas.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.